DNL310 - Phase 1/2 Clinical Trial
DNL310 - Phase 1/2 Clinical Trial
About This Event
Phase 1/2 24-week data presented July 25, 2021. Now enrolling cohort C, noted November 4, 2021. Phase 2/3 trial to be initiated 1H 2022. Details of Phase 2/3 and additional data from Phase 1/2 data to be discussed at the WORLDSymposium, February 7-11, 2022.
Why This Event Matters
Regulatory milestones can be important for biotech and pharmaceutical names because decisions may affect timelines, labeling, and commercial prospects. Outcomes are uncertain until confirmed by the company or agency materials; this listing is informational. The date shown is February 7, 2022 (America/New_York).
Source summary: Phase 1/2 24-week data presented July 25, 2021. Now enrolling cohort C, noted November 4, 2021. Phase 2/3 trial to be initiated 1H 2022. Details of Phase 2/3 and additional data from Phase 1/2 data to be discussed at the WORLDSymposium, February 7-11, 2022.
This listing is associated with DNLI. Market participants may watch these names around the event window for volatility or news flow.
Event Details
Occurs
Related Tickers
Impact Likelihood
Source
Created By
Source
Created By
Frequently Asked Questions
- What is DNL310 - Phase 1/2 Clinical Trial?
- It is a stock market catalyst entry on Catacal—an event or release investors and traders may monitor. Details are summarized from the cited source and may be updated over time.
- When is DNL310 - Phase 1/2 Clinical Trial?
- The calendar shows Feb 7, 2022 (America/New_York). Verify the exact time and any changes using the source link when planning around the event.
- Why does DNL310 - Phase 1/2 Clinical Trial matter for investors?
- Regulatory outcomes can change timelines and risk profiles for drug and device developers.
- Which stocks or sectors could be affected?
- Symbols linked to this listing include DNLI; other names in the same industry group may also move with related news.
- How is this event categorized?
- Catacal groups this entry under "FDA Approval" for navigation. Categories help you find comparable catalysts and build a week-by-week watchlist.
Track Market-Moving Events
Monitor earnings, economic releases, lockups, conferences, and other catalysts that impact stocks.
View Catalyst CalendarComprehensive Calendar
Track earnings, product launches, FDA approvals, economic events, and more.
Impact Ratings
Know which catalysts have the greatest potential to impact stock prices.
Never Miss an Event
Get alerts and reminders so you're always prepared for market-moving events.
View Catalyst Calendar
Track upcoming market events